Ben F. Brian, IV - Publications

Pharmacology University of Minnesota - Minneapolis 

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Brian BF, Sauer ML, Greene JT, Senevirathne SE, Lindstedt AJ, Funk OL, Ruis BL, Ramirez LA, Auger JL, Swanson WL, Nunez MG, Moriarity BS, Lowell CA, Binstadt BA, Freedman TS. A dominant function of LynB kinase in preventing autoimmunity. Science Advances. 8: eabj5227. PMID 35452291 DOI: 10.1126/sciadv.abj5227  0.642
2022 Brian BF, Sjaastad FV, Freedman TS. SH3-domain mutations selectively disrupt Csk homodimerization or PTPN22 binding. Scientific Reports. 12: 5875. PMID 35393453 DOI: 10.1038/s41598-022-09589-9  0.651
2021 Greene JT, Brian BF, Senevirathne SE, Freedman TS. Regulation of myeloid-cell activation. Current Opinion in Immunology. 73: 34-42. PMID 34601225 DOI: 10.1016/j.coi.2021.09.004  0.651
2020 Brian BF, Guerrero CR, Freedman TS. Immunopharmacology and Quantitative Analysis of Tyrosine Kinase Signaling. Current Protocols in Immunology. 130: e104. PMID 32931655 DOI: 10.1002/Cpim.104  0.665
2019 Brian BF, Jolicoeur AS, Guerrero CR, Nunez MG, Sychev ZE, Hegre SA, Sætrom P, Habib N, Drake JM, Schwertfeger KL, Freedman TS. Unique-region phosphorylation targets LynA for rapid degradation, tuning its expression and signaling in myeloid cells. Elife. 8. PMID 31282857 DOI: 10.7554/Elife.46043  0.677
Show low-probability matches.